Hyperinsulinemia is associated with the incidence of hypertension and dyslipidemia in middle-aged men

Diabetes

Volumn 47, Issue 2, 1998, Pages 270-275

  Salonen, Jukka T ^a   Lakka, Timo A ^a,b   Lakka, Hanna Maaria ^a   Valkonen, Veli Pekka ^a   Everson, Susan A ^c   Kaplan, George A ^c  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; LIPID;

ADULT; ARTICLE; BLOOD PRESSURE; BODY WEIGHT; CONTROLLED STUDY; DYSLIPIDEMIA; HUMAN; HYPERINSULINEMIA; HYPERTENSION; INSULIN METABOLISM; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; RISK FACTOR;

EID: 0031952565     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.47.2.270     Document Type: Article

References (37)

1. Reaven GM: A syndrome of resistance to insulin-stimulated uptake (Syndrome X). Definitions and implications. Cardiovasc Risk Factors 3:2-11, 1993
2. Laakso M: The possible pathophysiology of insulin resistance syndrome. Cardiovasc Risk Factors 3:55-66, 1993
3. Ferrannini E, Buzzicoli G, Bonadonna R, Giorico MA, Oleggini M, Graziadei L, Pedrinelli R, Brandi L, Bevilacoua S: Insulin resistance in essential hypertension, N Engl J Med 317:350-357, 1987
4. Zavaroni I, Bonora E, Pagliara M, Dall'Aglio E, Luchetti L, Buonanno G, Bonati BA, Bergonzani M, Gnudi L, Passen M, Reaven G: Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance. N Engl J Med 320:702-706, 1989
5. Collins VR, Dowse GK, Finch CF, Zimmet PZ: An inconsistent relationship between insulin and blood pressure in three Pacific Island populations. J Clin Epidemiol 43:1369-1378, 1990
6. Saad MF, Knowler WC, Pettitt DJ, Nelson RG, Mott DM, Bennett PH: Insulin and hypertension: relationship to obesity and glucose intolerance in Pima indians. Diabetes 39:1430-1435, 1990
7. Dowse GK, Collins VR, Alberti GMM, Zimmet PZ, Tuomilehto J, Chitson P, Gareboo H: Insulin and blood pressure levels are not independently related in Mauritanians of Asian Indian, Creole, or Chinese origin. J Hypertens 11:297-307, 1993
8. Saad MF, Lillioja S, Nyomba BL, Castillo C, Ferraro R, DeGregorio M, Ravussin E, Knowler WC, Bennett PH, Howard BV, Bogardus C: Racial differences in the relation between blood pressure and insulin resistance. N Engl J Med 324:733-739, 1991
9. Hall JE, Summers RL, Brands MW, Keen H, Alonso-Galicia M: Resistance to metabolic actions of insulin and its role in hypertension. Am J Hypertens 7:772-788, 1994
10. Garg A: Insulin resistance in the pathogenesis of dyslipidemia. Diabetes Care 19:387-389, 1996
11. Sowers JR, Standley PR, Ram JL, Jacober S, Simpson L, Rose K: Hyperinsulinemia, insulin resistance, and hyperglycemia: contributing factors in the pathogenesis of hypertension and atherosclerosis. Am J Hypertens 6:260S-270S, 1993
12. Taskinen M-R: Insulin resistance and lipoprotein metabolism, Curr Opin Lipidol 6:153-160, 1995
13. Reaven GM: Banting Lecture 1988: Role of insulin resistance in human disease. Diabetes 37:1595-1607, 1988
14. Haffner SM, Valdez RA, Hazuda HP, Mitchell BD, Morales PA, Stern MP: Prospective analysis of the insulin resistance syndrome (Syndrome X). Diabetes 41:715-722, 1992
15. Skarfors ET, Lithell HO, Selenius I: Risk factors for the development of hypertension: a 10-year longitudinal study in middle-aged men. J Hypertens 9:217-223, 1991
16. Lissner L, Bengtsson C, Lapidus L, Kristjansson K, Wedel H: Fasting insulin in relation to subsequent blood pressure changes and hypertension in women. Hypertension 20:797-801, 1992
17. Shetterly SM, Rewers M, Hamman RF, Marshall JA: Patterns and predictors of hypertension incidence among Hispanics and non-Hispanic whites: the San Luis Valley Diabetes Study. J Hypertens 12:1095-1102, 1994
18. Mykkänen L, Kuusisto J, Haffner S, Pyörälä K, Laakso M: Hyperinsulinemia predicts multiple atherogenic changes in lipoproteins in elderly subjects. Arterioscler Thromb 14:518-526, 1994
19. Salonen JT: Is there a continuing need for longitudinal epidemiologic research? The Kuopio Ischaemic Heart Disease Risk Factor Study. Ann Clin Res 20:46-50, 1988
20. Keys A: Seven Countries: A Multivariate Analysis of Death and Coronary Heart Disease. Cambridge, Massachusetts, Harvard University Press, 1980
21. Everson SA, Kaplan GA, Goldberg DE, Salonen JT: Anticipatory blood pressure response to exercise predicts future high blood pressure in middle-aged men. Hypertension 27:1059-1064, 1996
22. 3 subfractions and the risk of acute myocardial infarction: a prospective population study in Eastern Finnish men. Circulation 84:129-139, 1991
23. Pyörälä K, De Backer G, Graham L, Poole-Wilson P, Wood D: Prevention of coronary heart disease in clinical practice: recommendations of the task force of the European Society of Cardiology, European Atherosclerosis Society, and European Society of Hypertension. Eur Heart J 15:1300-1331, 1994
24. Salonen JT, Nyyssönen K, Korpela H, Tuomilehto J, Seppänen R, Salonen R: High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation 86:803-811, 1992
25. Lakka TA, Venäläinen JM, Rauramaa R, Salonen R, Tuomilehto J, Salonen JT: Relation of leisure-time physical activity to the risk of acute myocardial infarction in men. N Engl J Med 330:1549-1554, 1994
26. Salonen JT, Nyyssönen K, Tuomainen T-P, Mäenpää PH, Korpela H, Kaplan GA, Lynch J, Helmrich S, Salonen R: Increased risk of non-insulin-dependent diabetes mellitus at low plasma vitamin E concentrations: a four-year follow-up study in men. BMJ 311:1124-1127, 1995
27. Lynch JL, Helmrich SP, Lakka TA, Kaplan GA, Cohen RD, Salonen R, Salonen JT: Moderately intense physical activities and high levels of cardiorespiratory fitness reduce the risk of non-insulin-dependent diabetes mellitus in middle-aged men. Arch Intern Med 156:1307-1314, 1996
28. Tuomainen T-P, Nyyssönen K, Salonen R, Tervahauta A, Korpela H, Lakka T, Kaplan GA, Salonen JT: Body iron stores are associated with serum insulin and blood glucose concentrations: population study in 1,013 eastern Finnish men. Diabetes Care 20:426-428, 1997
29. Scherrer U, Randin D, Vollenweider P, Vollenweider L, Nicod P: Nitric oxide accounts for insulin's vascular effects in humans. J Clin Invest 94:2511-2515, 1994
30. Feldman RD, Bierbrier GS: Insulin-mediated vasodilation: impairment with increased blood pressure and body mass. Lancet 342:707-709, 1993
31. Anderson EA, Mark AL: The vasodilator action of insulin: implications for the insulin hypothesis of hypertension. Hypertension 21:129-135, 1993
32. Baron AD: Hemodynamic actions of insulin. Am J Physiol 267:E187-E202, 1994
33. Suzuki M, Shinozaki K, Kanazawa A, Hara Y, Hattori Y, Tsushima M, Harano Y: Insulin resistance as an independent risk factor for carotid wall thickening. Hypertension 28:593-598, 1996
34. Laakso M, Sarlund H, Salonen R, Suhonen M, Pyörälä K, Salonen JT, Karhapää P: Asymptomatic atherosclerosis and insulin resistance. Arterioscler Thromb 11:1068-1076, 1991
35. Lithell HOL: Effect of antihypertensive drugs on insulin, glucose, and lipid metabolism. Diabetes Care 14:203-209, 1991
36. A Working Party: Hypertension in people with type 2 (non-insulin-dependent) diabetes. International Diabetes Federation Consensus Guidelines. Brussels, IDF, 1997
37. Kasiske BL, Ma JZ, Kalil RS, Louis TA: Effects of antihypertensive therapy on serum lipids. Ann Intern Med 122:133-141, 1995